Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Hematopoietic Stem Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT01666080
What this trial is testing

Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

Who this might be right for
Hematologic DisordersHemoglobinopathiesImmunodeficiencies
Masonic Cancer Center, University of Minnesota 30
Early research (Phase 1)WithdrawnNCT02677246
What this trial is testing

Denosumab for Prevention of Bone Complications After Bone Marrow Transplantation in Children

Who this might be right for
Disorder Related to Bone Marrow Transplantation
St. Justine's Hospital
Testing effectiveness (Phase 2)Study completedNCT00064311
What this trial is testing

Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
National Institutes of Health Clinical Center (CC)
Large-scale testing (Phase 3)Looking for participantsNCT06705062
What this trial is testing

Study Comparing Reduced Versus Standard Dose Post-transplantation Cyclophosphamide in Combination With Post-engraftment Anti-thymoglobin as Graft Versus Host Disease Prophylaxis in Alternative Donor Peripheral Stem Cell Transplantation

Who this might be right for
Allogeneic Hematopoietic Cell TransplantGraft Versus Host Disease
Shanghai Jiao Tong University School of Medicine 316
Early research (Phase 1)Looking for participantsNCT06575296
What this trial is testing

Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant

Who this might be right for
Acute LeukemiaAcute Leukemia of Ambiguous LineageAcute Lymphoblastic Leukemia+5 more
City of Hope Medical Center 27
Testing effectiveness (Phase 2)Study completedNCT00491634
What this trial is testing

Treosulfan-based Conditioning for Transplantation in AML/MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Dr. Avichai Shimoni MD 24
Large-scale testing (Phase 3)UnknownNCT04123392
What this trial is testing

Decitabine + BUCY vs BUCY Conditioning Regimen for TP53+ Myeloid Tumors Undergoing Allo-HSCT

Who this might be right for
TP53Myeloid TumorsConditioning+1 more
Nanfang Hospital, Southern Medical University 196
Early research (Phase 1)Active Not RecruitingNCT03613532
What this trial is testing

Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)Chronic Myelomonocytic Leukemia (CMML)+2 more
Jacqueline Garcia, MD 102
Not applicableUnknownNCT05656599
What this trial is testing

Immune Reconstitution to CMV After HSCT: Impact of Clinical Factors and Therapy Strategies

Who this might be right for
CMV InfectionHematopoietic Stem Cell Transplantation
Peking University People's Hospital 120
Early research (Phase 1)Study completedNCT01445132
What this trial is testing

Adoptive Cell Therapy for B-Cell Cancers in Patients After Stem Cell Transplantation

Who this might be right for
Chronic Lymphocytic Leukemia
National Cancer Institute (NCI) 11
Testing effectiveness (Phase 2)Ended earlyNCT01139164
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation With Reduced Intensity Pre-transplant Conditioning for the Treatment of High-risk Hematological Malignancies (V3)

Who this might be right for
Hematological Malignancies
Medical University of South Carolina 78
Not applicableStudy completedNCT04789863
What this trial is testing

Implementation and Testing of an eHealth Integrated Model of Care for Patients Receiving Allogeneic Stem Cell Transplantation: The SMILe Project

Who this might be right for
Stem Cell Transplantation
University of Basel 80
Testing effectiveness (Phase 2)Looking for participantsNCT05270200
What this trial is testing

Single Arm Study of Post-transplant Azacitidine and Chidamide for Prevention of Acute Myelogenous Leukemia Relapse

Who this might be right for
Leukemia, Myeloid, Acute
Zhujiang Hospital 40
Large-scale testing (Phase 3)Looking for participantsNCT01949129
What this trial is testing

Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia

Who this might be right for
Acute Lymphoblastic Leukaemia
St. Anna Kinderkrebsforschung 1,800
Testing effectiveness (Phase 2)Study completedNCT01379209
What this trial is testing

Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)

Who this might be right for
Graft Versus Host Disease
Regimmune Corporation 68
Early research (Phase 1)Study completedNCT01822509
What this trial is testing

Ipilimumab or Nivolumab in Treating Patients With Relapsed Hematologic Malignancies After Donor Stem Cell Transplant

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplant RecipientMyeloproliferative NeoplasmRecurrent Acute Lymphoblastic Leukemia+8 more
National Cancer Institute (NCI) 71
Large-scale testing (Phase 3)UnknownNCT04000698
What this trial is testing

Personalized Targeted Preparative Regimen Before T-depleted Allogeneic HSCT in Children With Chemoresistent Acute Leukemias

Who this might be right for
Refractory Acute Myeloid LeukemiaRefractory Acute Lymphoblastic Leukemia
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 25
Testing effectiveness (Phase 2)Study completedNCT00673114
What this trial is testing

Unrelated Cord Blood Transplant Plus a Haplo-Identical (Half-Matched), T-Cell Depleted Stem Transplant From a Related Donor for Subjects With High Risk Malignancies

Who this might be right for
Hematologic MalignancyMyelodysplastic Syndrome (MDS)Aplastic Anemia
Joanne Kurtzberg, MD 3
Not applicableLooking for participantsNCT07718204
What this trial is testing

The MedMemos Study: Promoting Adherence to Medications in Pediatric Bone Marrow Transplant Patients

Who this might be right for
Hematopoietic Cell Transplant
Nationwide Children's Hospital 25
Early research (Phase 1)Looking for participantsNCT06551584
What this trial is testing

Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoid LeukemiaMixed Phenotype Acute Leukemia+1 more
Stanford University 24
Next Page